 NEW YORK, May 24, 2021 PRNewswire -- Hoth Therapeutics , Inc. NASDAQ: HOTH, a patient-focused biopharmaceutical company, announced today that it will be an exhibitor at the American Society of Clinical Oncology ASCO Annual Meeting. Attendees will be able to visit the Hoth Therapeutics booth virtually starting May 24th through July 6, 2021. 